TEVA ▼ -1.0% - Teva Pharmaceutical Industries Limited $TEVA - Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy Teva announced a proposed acquisition of a novel neuroscience product as part of its Pivot to Growth strategy, yet shares declined 1.0% today. While the acquisition signals the company's commitment to disciplined business development and portfolio expansion in neuroscience, investors appear cautious about the deal's financial terms or timing in the current market environment. 28-AUG-2026 06:17 AM ET